|
|
|
|
|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
doi: 10.1242/10.1242/dev.00355
1 Department of Biological Sciences, Columbia University, New York, NY 10027
USA
2 Tufts University School of Veterinary Medicine, North Grafton, MA 01536
USA
3 Laboratory of Molecular Oncology, MGH Cancer Center, Charlestown, MA 02129,
USA
* Author for correspondence (e-mail: ly63{at}columbia.edu)
Accepted 20 December 2002
Release of E2F1/DP1 heterodimers from repression mediated by the retinoblastoma tumor suppressor (pRB) triggers cell cycle entry into S phase, suggesting that E2F1 and DP1 proteins must act in unison, either to facilitate or to suppress cell-cycle progression. In stark contrast to the milder phenotypes that result from inactivation of E2Fs, we report that loss of Dp1 leads to death in utero because of the failure of extra-embryonic development. Loss of Dp1 compromises the trophectoderm-derived tissues — specifically, the expansion of the ectoplacental cone and chorion, and endoreduplication in trophoblast giant cells. Inactivation of p53 is unable to rescue the Dp1-deficient embryonic lethality. Thus, DP1 is absolutely required for extra-embryonic development and consequently embryonic survival, consistent with E2F/DP1 normally acting to promote growth in vivo.
Key words: E2F transcription, Trophectoderm, Mouse
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
 |
|
  Y. Masuhiro, K. Kayama, A. Fukushima, K. Baba, M. Soutsu, Y. Kamiya, M. Gotoh, N. Yamaguchi, and S. Hanazawa SOCS-3 Inhibits E2F/DP-1 Transcriptional Activity and Cell Cycle Progression via Interaction with DP-1 J. Biol. Chem., November 14, 2008; 283(46): 31575 - 31583. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Qiao, L. Di Stefano, C. Tian, Y.-Y. Li, Y.-H. Yin, X.-P. Qian, X.-W. Pang, Y. Li, M. A. McNutt, K. Helin, et al. Human TFDP3, a Novel DP Protein, Inhibits DNA Binding and Transactivation by E2F J. Biol. Chem., January 5, 2007; 282(1): 454 - 466. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Agromayor, E. Wloga, B. Naglieri, J. Abrashkin, K. Verma, and L. Yamasaki Visualizing Dynamic E2F-Mediated Repression In Vivo Mol. Cell. Biol., June 15, 2006; 26(12): 4448 - 4461. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Datta, J. Sen, J. Hagen, C. K. Korgaonkar, M. Caffrey, D. E. Quelle, D. E. Hughes, T. J. Ackerson, R. H. Costa, and P. Raychaudhuri ARF Directly Binds DP1: Interaction with DP1 Coincides with the G1 Arrest Function of ARF Mol. Cell. Biol., September 15, 2005; 25(18): 8024 - 8036. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Ishida, Y. Masuhiro, A. Fukushima, J. G. M. Argueta, N. Yamaguchi, S. Shiota, and S. Hanazawa Identification and Characterization of Novel Isoforms of Human DP-1: DP-1{alpha} REGULATES THE TRANSCRIPTIONAL ACTIVITY OF E2F1 AS WELL AS CELL CYCLE PROGRESSION IN A DOMINANT-NEGATIVE MANNER J. Biol. Chem., July 1, 2005; 280(26): 24642 - 24648. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Y. Chang, D. M. Bryce, S. J. A. D'Souza, and L. Dagnino The DP-1 Transcription Factor Is Required for Keratinocyte Growth and Epidermal Stratification J. Biol. Chem., December 3, 2004; 279(49): 51343 - 51353. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. T. Tilli, S. L. Hudgins, M. S. Frech, E. D. Halama, J.-P. Renou, and P. A. Furth Loss of Protein Phosphatase 2A Expression Correlates with Phosphorylation of DP-1 and Reversal of Dysplasia through Differentiation in a Conditional Mouse Model of Cancer Progression Cancer Res., November 15, 2003; 63(22): 7668 - 7673. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. de Bruin, L. Wu, H. I. Saavedra, P. Wilson, Y. Yang, T. J. Rosol, M. Weinstein, M. L. Robinson, and G. Leone Rb function in extraembryonic lineages suppresses apoptosis in the CNS of Rb-deficient mice PNAS, May 27, 2003; 100(11): 6546 - 6551. [Abstract] [Full Text] [PDF]
|
|
